SUNRUN INC (RUN)

US86771W1053 - Common Stock

11.9  +0.95 (+8.68%)

After market: 11.9397 +0.04 (+0.33%)

Fundamental Rating

2

RUN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 86 industry peers in the Electrical Equipment industry. RUN has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, RUN is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

RUN had negative earnings in the past year.
In the past year RUN has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: RUN reported negative net income in multiple years.
RUN had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -7.85%, RUN perfoms like the industry average, outperforming 58.33% of the companies in the same industry.
RUN has a Return On Equity (-30.68%) which is in line with its industry peers.
Industry RankSector Rank
ROA -7.85%
ROE -30.68%
ROIC N/A
ROA(3y)-2.48%
ROA(5y)-1.64%
ROE(3y)-9.79%
ROE(5y)-5.9%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 7.22%, RUN is not doing good in the industry: 70.24% of the companies in the same industry are doing better.
RUN's Gross Margin has declined in the last couple of years.
RUN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-28.06%
GM growth 5Y-24.6%

1

2. Health

2.1 Basic Checks

RUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RUN has been increased compared to 1 year ago.
Compared to 5 years ago, RUN has more shares outstanding
Compared to 1 year ago, RUN has a worse debt to assets ratio.

2.2 Solvency

RUN has an Altman-Z score of 0.00. This is a bad value and indicates that RUN is not financially healthy and even has some risk of bankruptcy.
RUN has a Altman-Z score (0.00) which is in line with its industry peers.
A Debt/Equity ratio of 1.95 is on the high side and indicates that RUN has dependencies on debt financing.
RUN has a worse Debt to Equity ratio (1.95) than 82.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.95
Debt/FCF N/A
Altman-Z 0
ROIC/WACCN/A
WACC6.25%

2.3 Liquidity

RUN has a Current Ratio of 1.26. This is a normal value and indicates that RUN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of RUN (1.26) is worse than 82.14% of its industry peers.
A Quick Ratio of 0.96 indicates that RUN may have some problems paying its short term obligations.
RUN has a worse Quick ratio (0.96) than 69.05% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.96

5

3. Growth

3.1 Past

RUN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1059.74%.
The Revenue has decreased by -2.66% in the past year.
Measured over the past years, RUN shows a very strong growth in Revenue. The Revenue has been growing by 24.35% on average per year.
EPS 1Y (TTM)-1059.74%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-651.72%
Revenue 1Y (TTM)-2.66%
Revenue growth 3Y34.82%
Revenue growth 5Y24.35%
Revenue growth Q2Q-15.2%

3.2 Future

The Earnings Per Share is expected to grow by 23.72% on average over the next years. This is a very strong growth
Based on estimates for the next years, RUN will show a quite strong growth in Revenue. The Revenue will grow by 12.58% on average per year.
EPS Next Y83.11%
EPS Next 2Y37.23%
EPS Next 3Y23.98%
EPS Next 5Y23.72%
Revenue Next Year-1.14%
Revenue Next 2Y7.05%
Revenue Next 3Y10.77%
Revenue Next 5Y12.58%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

RUN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year RUN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as RUN's earnings are expected to grow with 23.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.23%
EPS Next 3Y23.98%

0

5. Dividend

5.1 Amount

RUN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SUNRUN INC

NASDAQ:RUN (5/3/2024, 7:16:38 PM)

After market: 11.9397 +0.04 (+0.33%)

11.9

+0.95 (+8.68%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.59B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.85%
ROE -30.68%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 7.22%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 1.95
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.26
Quick Ratio 0.96
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-1059.74%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y83.11%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-2.66%
Revenue growth 3Y34.82%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y